tiprankstipranks
Trending News
More News >
Spago Nanomedical AB (DE:7UX)
FRANKFURT:7UX
Germany Market

Spago Nanomedical AB (7UX) Income Statement

Compare
0 Followers

Spago Nanomedical AB Income Statement

Last quarter (Q4 2024), Spago Nanomedical AB's total revenue was kr617.00K, a decrease of -15.60% from the same quarter last year. In Q4, Spago Nanomedical AB's net income was kr-7.83M. See Spago Nanomedical AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
kr 1.91Mkr 1.20Mkr 1.05Mkr 660.00Kkr 342.00K
Gross Profit
kr -12.36Mkr -23.28Mkr -15.60Mkr -16.78Mkr -416.00K
Operating Expenses
kr 21.36Mkr 19.79Mkr 23.48Mkr 22.29Mkr 18.54M
Depreciation and Amortization
kr 312.00Kkr 281.00Kkr 356.00Kkr 376.00Kkr 362.00K
EBITDA
kr -33.40Mkr -42.22Mkr -38.73Mkr -38.69Mkr -18.59M
Operating Income
kr -33.71Mkr -42.51Mkr -39.47Mkr -39.19Mkr -18.96M
Other Income/Expenses
kr 1.20Mkr 282.00Kkr -112.00Kkr -4.00Kkr 26.00K
Pretax Income
kr -32.51Mkr -42.22Mkr -39.20Mkr -39.07Mkr -18.93M
Net Income
kr -32.51Mkr -42.22Mkr -39.31Mkr -39.08Mkr -18.90M
Per Share Metrics
Basic EPS
kr -0.09kr -0.22kr -0.30kr -0.46kr -0.32
Diluted EPS
kr -0.09kr -0.22kr -0.30kr -0.46kr -0.32
Weighted Average Shares Outstanding
348.20M 195.96M 133.62M 83.66M 57.99M
Weighted Average Shares Outstanding (Diluted)
348.20M 195.96M 133.62M 83.66M 57.99M
Currency in SEK

Spago Nanomedical AB Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis